Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07469852) titled 'Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Liverpool John Moores University
Condition:
Caffeine
Placebo - Control
No Pill
Intervention:
Drug: Caffeine (300 mg)
Other: Placebo
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: January 12, 2026
Target Sample Size: 15
Countries of Recruitment:
United Kingdom
To know ...